Health Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer By October 26, 2026 1 Min Read 0 🕑 1 min readMerck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug. Source: NPR Topics: Health — Read the original story Share:FacebookXWhatsAppRelated Stories Special ed diaries: Teachers tell NPR about their most joyous, most difficult momentsSome people with meat allergies from alpha-gal syndrome turn to exotic alternativesAttackers kill nurse, severely injure health worker responding to Ebola case in CongoRelated Posts:New mRNA Vaccine Reduces Risk of Melanoma Recurrence…Moderna and Merck say their mRNA cancer vaccine cut…mRNA cancer vaccine helps reduce chances of melanoma…Moderna shares plunge after cancer vaccine data…Merck CEO tells CNBC he expects breakthrough cancer…Moderna has a plan to revolutionize how certain…
